Legal Representation
Attorney
Michael F. Swartz
USPTO Deadlines
Application History
28 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 9, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Dec 9, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Nov 17, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Nov 17, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Oct 16, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| May 13, 2025 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Oct 16, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| May 13, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Nov 19, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 24, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 24, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 4, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 22, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 19, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 19, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 19, 2024 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Jun 17, 2024 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Jun 17, 2024 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Jun 17, 2024 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Apr 18, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 17, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 17, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 6, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 6, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 6, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 25, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 10, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 23, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Biological preparation for use in cell cultures other than for medical or veterinary use; Biological preparations for use in industry and science; Cell culture media for scientific and research use; Cell culture reagents for scientific and research use; Cells for scientific and research use; Chemical preparations for scientific purposes; Enzymes for scientific and research purposes; Protein in raw material form for scientific and medical research; Culture media for cultivating microbial, plant, and animal cells, particularly, bacterial, fungal, algal, mammalian, insect, and stem cells, other than for medical or veterinary use
First Use Anywhere:
20240900
First Use in Commerce:
20240900
Class 005
Amino acids for medical purposes; Biological preparations for the treatment of oncological disorders, autoimmune diseases, metabolic conditions, neurodegenerative diseases, cardiovascular diseases, genetic diseases, hematological disorders and infectious diseases; Cell growth media for growing cells for medical or clinical use; Cells for medical or clinical use; Culture media for cultivating microbial, plant, and animal cells, particularly, bacterial, fungal, algal, mammalian, insect, and stem cells, for medical or veterinary use; Enzyme preparations for medical purposes; Glucose for medical purposes
First Use Anywhere:
20240900
First Use in Commerce:
20240900
Class 042
Biological research; Biotechnology research; DNA screening for scientific research purposes; Medical research services; Pharmaceutical research services; Providing reagent sample testing and diagnostic services for others for scientific research purposes; Scientific laboratory services; Scientific research; Scientific research consulting; Technical consulting in the field of pharmaceutical studies
First Use Anywhere:
20240900
First Use in Commerce:
20240900
Classification
International Classes
001
005
042